Showing results (21-30 of 233) with videos related to

Sort By:
Pageof 24
British Journal of Cancer|January 1, 1997
High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancerA G Zeimet, M Widschwendter, M Uhl-Steidl, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1996
[Immunostimulating protein 90K in ovarian carcinoma]A G Zeimet, C Marth, D Fuchs, et al.
Gynecologic Oncology|January 1, 1997
Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometriumC Marth, G Windbichler, E Petru, et al.
Oncology|September 1, 1995
Prognostic value of CD44 splice variant expression in ovarian cancerM Uhl-Steidl, E Müller-Holzner, A G Zeimet, et al.
International Journal of Cancer|September 27, 1996
Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancerA G Zeimet, C Natoli, M Herold, et al.
Cancer Research|September 1, 1997
Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cellsC Marth, A G Zeimet, M Widschwendter, et al.
Geburtshilfe Und Frauenheilkunde|November 1, 1989
[The intraperitoneal installation of gamma interferon for the treatment of refractory ovarian carcinoma]C Marth, R Mull, G Gastl, et al.
International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Fur Vitamin- Und Ernahrungsforschung. Journal International De Vitaminologie Et De Nutrition|January 1, 1978
Vitamin B6 nutriture during pregnancyL Reinken, O Dapunt
Pageof 24